Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial.
Ola Mohamed EzzattIman M HelmyPublished in: Clinical oral investigations (2018)
The study proved the benefits of topical pimecrolimus in early management of painful lesions of OLP and its ability to inhibit CSCs, suggesting a possible role in reducing risk of malignant transformation.
Keyphrases